Chronic nicotine exposure and acute kidney injury: New concepts and experimental evidence

Nephrology Dialysis Transplantation

Volumn 28, Issue 6, 2013, Pages 1329-1331

  Speeckaert, Marijn M ^a   Delanghe, Joris R ^a   Vanholder, Raymond C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

acute kidney injury; nicotine; pathways; tobacco

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE TRIPHOSPHATE; CIGARETTE SMOKE; CYTOCHROME C; EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KLOTHO PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NICOTINE; NICOTINIC AGENT; ORGANIC CATION TRANSPORTER 2; PROTEASOME; PROTEIN P53; PROTEIN P66SHC; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DISEASE EXACERBATION; GENETIC POLYMORPHISM; HUMAN; LONG TERM EXPOSURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEINURIA; RISK FACTOR; SEPSIS; SMOKING; TOBACCO DEPENDENCE;

ACUTE KIDNEY INJURY; NICOTINE; PATHWAYS; TOBACCO;

ACUTE KIDNEY INJURY; ANIMALS; KIDNEY TUBULES, PROXIMAL; MALE; NICOTINE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SHC SIGNALING ADAPTOR PROTEINS;

EID: 84879849497     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft019     Document Type: Article

References (33)

1. Mittalhenkle A, Stehman-Breen CO, Shlipak MG et al. Cardiovascular risk factors and incident acute renal failure in older adults: the cardiovascular health study. Clin J Am Soc Nephrol 2008; 3: 450-456
2. Orth SR, Ritz E. The renal risks of smoking: an update. Curr Opin Nephrol Hypertens 2002; 11: 483-488
3. Orth SR, Hallan SI. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients-absence of evidence or evidence of absence? Clin J Am Soc Nephrol 2008; 3: 226-236
4. Halimi JM, Giraudeau B, Vol S et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 2000; 58: 1285-1292
5. Briganti EM, Branley P, Chadban SJ et al. Smoking is associated with renal impairment and proteinuria in the normal population: The AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis 2002; 40: 704-712
6. Rossing P, Hougaard P, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 2002; 25: 859-864
7. Haroun MK, Jaar BG, Hoffman SC et al. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 2003; 14: 2934-2941
8. Ejerblad E, Fored CM, Lindblad P et al. Association between smoking and chronic renal failure in a nationwide populationbased case-control study. J Am Soc Nephrol 2004; 15: 2178-2185
9. Hallan SI, Orth SR. Smoking is a risk factor in the progression to kidney failure. Kidney Int 2011; 80: 516-523
10. Agarwal PK, Hellemons ME, Zelle DM et al. Smoking is a risk factor for graft failure and mortality after renal transplantation. Am J Nephrol 2011; 34: 26-31
11. Arany I, Clark JS, Reed DK et al. Chronic nicotine exposure augments renal oxidative stress and injury through transcriptional activation of p66shc. Nephrol Dial Transplant 2013; doi: 10.1093/ndt/gfs596
12. Arany I, Grifoni S, Clark JS et al. Chronic nicotine exposure exacerbates acute renal ischemic injury. Am J Physiol Renal Physiol 2011; 301: F125-F133
13. Arany I, Faisal A, Nagamine Y et al. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells. J Biol Chem 2008; 283: 6110-6117
14. Arany I, Faisal A, Clark JS et al. p66SHC-mediated mitochondrial dysfunction in renal proximal tubule cells during oxidative injury. Am J Physiol Renal Physiol 2010; 298: F1214-F1221
15. Arany I, Reed DK, Grifoni SC et al. A novel U-STAT3-dependent mechanism mediates the deleterious effects of chronic nicotine exposure on renal injury. Am J Physiol Renal Physiol 2012; 302: F722-F729
16. Orth SR. Smoking and the kidney. J Am Soc Nephrol 2002; 13: 1663-1672
17. Chatterjee PK, Yeboah MM, Dowling O et al. Nicotinic acetylcholine receptor agonists attenuate septic acute kidney injury in mice by suppressing inflammation and proteasome activity. PLoS One 2012; 7: e35361
18. Shimizu H, Bolati D, Adijiang A et al. Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate. Am J Physiol Cell Physiol 2010; 299: C1110-C1117
19. Shimizu H, Bolati D, Adijiang A et al. Indoxyl sulfate downregulates renal expression of Klotho through production of ROS and activation of nuclear factor-?B. Am J Nephrol 2011; 33: 319-324
20. Zgoda-Pols JR, Chowdhury S, Wirth M et al. Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol 2011; 255: 48-56
21. Odoni G, Ogata H, Viedt C et al. Cigarette smoke condensate aggravates renal injury in the renal ablation model. Kidney Int 2002; 61: 2090-2098
22. Hukkanen J, Jacob P, 3rd, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005; 57: 79-115
23. Agarwal PK, van den Born J, van Goor H et al. Renoprotective effects of long-term oral nicotine in a rat model of spontaneous proteinuria. Am J Physiol Renal Physiol 2012; 302: F895-F904
24. Sadis C, Teske G, Stokman G et al. Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic antiinflammatory pathway. PLoS One 2007; 2: e469
25. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007; 117: 289-296
26. Benowitz NL, Lessov-Schlaggar CN, Swan GE. Genetic influences in the variation in renal clearance of nicotine and cotinine. Clin Pharmacol Ther 2008; 84: 243-247
27. Benowitz NL, Jacob P, 3rd. Nicotine renal excretion rate influences nicotine intake during cigarette smoking. J Pharmacol Exp Ther 1985; 234: 153-155
28. Benowitz NL, Kuyt F, Jacob P, 3rd et al. Cotinine disposition and effects. Clin Pharmacol Ther 1983; 34: 604-611.
29. Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 2004; 84: 987-1049
30. Aoki M, Terada T, Kajiwara M et al. Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation. Am J Physiol Renal Physiol 2008; 295: F165-F170
31. International Transporter ConsortiumGiacomini KM, Huang SM et al. Membrane transporters in drug development. Nat Rev Drug Discov 2010; 9: 215-236
32. Filipski KK, Mathijssen RH, Mikkelsen TS et al. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. Clin Pharmacol Ther 2009; 86: 396-402
33. Nies AT, Hofmann U, Resch C et al. Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs). PLoS One 2011; 6: e22163